HCV Self-testing in Malaysia

Launched by FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS, SWITZERLAND · Jul 27, 2021

Keywords

ClinConnect Summary

Malaysia is an upper middle-income country with a population of more than 32 million, comprising thirteen states and three federal territories. It is estimated that the hepatitis C virus (HCV) seroprevalence in the general population of Malaysia is between 0.3% and 2.5%. In Malaysia, people who inject drugs represent just 0.24% (75 000) of the adult population; however, they are disproportionately affected by HCV, with an overall HCV prevalence of 67.5% to 89.9%. Other key populations in Malaysia at higher risk of HCV include 77 903 people living with human immunodeficiency virus (HIV, 0.24...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Eligible to access services on the JomTest online platform
• • Not known to be HCV antibody positive
• • Not tested for HCV within the last 6 months
• • Able to read and understand Bahasa Malaysia or English
• • Able to understand the scope of the study and provide online informed consent
• Exclusion Criteria:
• • • Self-reported previously confirmed positive HCV status (either antibody or RNA)